Interactive Workshop Will Feature Insights on Policy, Barriers and Key Factors for Successfully Launching a Biosimilar in China and Taiwan
NEW YORK, December 20, 2012—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, will host a workshop, “Biosimilars Opportunities & Challenges in Asia,” on January 11, 2013, at the Regent Taipei Hotel in Taipei, Taiwan. The workshop will highlight the most recent developments in the biosimilars space and their success in Asia, particularly in China and Taiwan and will offer an opportunity for a candid, mutual exchange of opinions and ideas.
The workshop will be a half-day session with presentations starting at 13:15. Kantar Health’s biosimilars experts and guest speakers will present on the following topics:
- 13:30-14:10 Strategic Business Models That Fit the Trend of the Coming Biosimilars Industry – C.J. Chang, Director, TTY Biopharm
- 14:10-14:50 Policy, Barriers and Opportunities for Biosimilar Products in Taiwan – W.F. Huang, Professor, National Yang Ming University
- 15:00-15:45 Key Factors to a Successful Biosimilar Business in Taiwan – Questa Lin, General Manager, Kantar Health Taiwan
- 15:45-16:30 Key Factors to a Successful Biosimilar Business in China – Simon Li, General Manager, Kantar Health China
To register for this free event or for more information, visit our website.
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With staff in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Stacy Sevcik, Marketing Manager, at email@example.com or +1-314-529-3062.